omniture

Skystar Bio-Pharmaceutical Announces Upcoming Interview With WallSt.net ( www.wallst.net )



XI'AN, China, Oct. 19 /Xinhua-PRNewswire-FirstCall/ -- Mr. Weibing Lu, Chief Executive Officer of Skystar Bio-Pharmaceutical Co., Ltd. (OTC Bulletin Board: SKBI) ("Skystar") will be featured in an exclusive interview with http://www.wallst.net on October 24, 2007, at 10:30 a.m. EST. The interview will be posted on www.wallst.net by 8:00 p.m. EST on October 24.

The interview will cover topics including Skystar's market potential, growth initiatives, competitive edge, recent news, and milestones for investors to watch for.

To hear the interview in its entirety, visit http://www.wallst.net, and click on "Interviews." The interview can be accessed either by locating the company's ticker symbol under the appropriate exchange on the left-hand column of the "Interviews" section of the site, or by entering the company's ticker symbol in the Search Archive window once it is posted.

About Skystar Bio-Pharmaceutical

Skystar Bio-Pharmaceutical Company is a China-based producer and distributor of vaccines, microorganisms and veterinary medication to cure and prevent disease in poultry, livestock, birds and pets. The company's product line consists of more than 100 products with over 50 additional products in the developmental stage. Skystar has formed strategic sales distribution networks throughout China. The company recently completed the first phase of construction of new state-of-the-art bio-pharmaceutical facilities covering an area of almost eight acres. The new facilities meet or exceed all Good Manufacturing Practice (GMP) Certification Standards and have received GMP Certification from the Chinese government. For additional information, please visit http://www.skystarbio-pharmaceutical.com .

About WallSt.net

www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. ( http://www.financialmediagroupinc.com ). The Web site is a leading provider of timely business news, executive interviews, multimedia content, and research tools. Financial Media Group, Inc. also owns http://www.mywallst.net , a financial social network for investors, and Financial Filings Corp. ( http://www.financialfilings.com ), a provider of media and compliance solutions to publicly traded companies. In addition to WallSt.net, WallStreet Direct, Inc. owns and operates WallStRadio ( http://www.wallstradio.com ), a business and finance podcast Web site. For a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp .

For more information, please contact:

Skystar Bio-Pharmaceutical Co., Ltd.

Scott Cramer

Director - U.S. Representative

Tel: +1-407-645-4433

Email: scramer@skystarbio-pharmaceutical.com

CCG Elite Investor Relations

Crocker Coulson, President

Email: crocker.coulson@ccgir.com

Leslie Richardson, Financial Writer

Tel: +1-310-231-8600 x122

Email: leslie.richardson@ccgir.com

WallSt.net

Nick Iyer

Tel: +1-800-4-WALL-ST

Source: Skystar Bio-Pharmaceutical Co., Ltd.
Related Stocks:
NASDAQ:SKBI
collection